Company · Biotech and pharma · Healthcare · Hardware
Every investor coverage indicates participated in a round Pictor raised.
Companies Pictor acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Graham Bailey | Senior Scientist | Wholesale Investor |
| Dr Thomas Schlumpberger | CEO | Wholesale Investor |
| Howard Moore | CEO | Wholesale Investor |
| Tadd Lazarus | Chief Medical Officer | Wholesale Investor |
Stories naming Pictor. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Diagnostics firm Pictor raised $6.1 million led by Marko Bogoievski and K1W1, and unveiled a partnership with US laboratory provider Mobility Health to launch its COVID-19 antibody test across several markets.
Diagnostics company Pictor is running COVID antibody assay trials across four countries and has raised $3,748,921 of a targeted $7 million Series F, with the shortfall to be offered at a higher share price.